Omicron shows evidence it can reinfect those who already had COVID, study says

Indonesia Berita Berita

Omicron shows evidence it can reinfect those who already had COVID, study says
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 Newsweek
  • ⏱ Reading Time:
  • 40 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 52%

'Previous infection used to protect against Delta, and now with Omicron it doesn't seem to be the case,' researcher Anne von Gottberg said.

South African scientists are warning that the Omicron variant could reinfect people who have already battled COVID-19, the Associated Press reported.has been published on reinfection rates in the country, and the results show an increased rate of reinfections attributed to Omicron compared to other variants.

One of the researchers involved in the study is Anne von Gottberg, a researcher at the University of Witwatersrand who participated in a briefing for the World Health Organization. She elaborated on the findings and stressed the effectiveness of vaccination against COVID-19. Scientists in South Africa and Botswana discovered the variant last week, with its exact origins currently being studied. The variant has been found in multiple countries, including the United States.South African scientists are warning that the Omicron variant could reinfect people who have already battled COVID-19. Above, a healthcare worker helps a patient to fill out a form before conducting a PCR COVID-19 test at the Lancet laboratory in Johannesburg, South Africa, on November 30, 2021.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

Newsweek /  🏆 468. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

COVID-19 Antibody Drug Likely Works Against Omicron, Companies SayCOVID-19 Antibody Drug Likely Works Against Omicron, Companies SayEarly lab studies show that a COVID-19 antibody treatment developed by GlaxoSmithKline and Vir Biotechnology could be effective against the Omicron variant.
Baca lebih lajut »

Why scientists — and much of the world — reacted so quickly to the omicron variantWhy scientists — and much of the world — reacted so quickly to the omicron variantThese early signs made omicron different from previous Covid variants, experts say.
Baca lebih lajut »

This interactive map shows where the Covid omicron variant has been detectedThis interactive map shows where the Covid omicron variant has been detectedFrom the U.S. to Germany and Saudi Arabia to Australia, the omicron Covid-19 variant has spread to dozens of countries globally.
Baca lebih lajut »

WHO says no evidence yet to support tailoring COVID-19 vaccines to OmicronWHO says no evidence yet to support tailoring COVID-19 vaccines to OmicronRyan, speaking at a social media event, said that if needed, however, the work was already underway in case Omicron-specific vaccines were needed. The agency said earlier on Friday that it was still studying the transmissibility and severity of the new variant.
Baca lebih lajut »

First U.S. case of omicron variant is found in CaliforniaFirst U.S. case of omicron variant is found in CaliforniaThe omicron Covid variant has been detected in California, the first confirmed U.S. case. The omicron variant of the coronavirus was first discovered in southern Africa.
Baca lebih lajut »

Factbox: What COVID-19 vaccine and drug makers have to say about OmicronFactbox: What COVID-19 vaccine and drug makers have to say about OmicronThe Omicron variant of the coronavirus has sparked fears that existing COVID-19 vaccines and treatment could be less effective against it.
Baca lebih lajut »



Render Time: 2025-03-06 13:13:19